Search results
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 4 days agoIn the deal valued at $13.90 per share,47,312 shares were sold. As a result of this transaction, Dubovsky Filip now holds 38,953 shares worth roughly $0.51 million. JP Morgan upgraded its < ...
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX)
ETF DAILY NEWS· 1 day agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Novavax& ...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 18 hours agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 4 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently ...
Novavax, Inc. (NASDAQ: NVAX) Today’s Hot Stock – Stocks Register
Stocks Register· 3 days agoNovavax, Inc. (NASDAQ:NVAX) traded at $14.79 at close of the session on Monday, May 20, made an upward move of 13.68% on its previous ...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 7 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 4 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...